2.6CHF
14.88 MCHF
988.44 KCHF
2.85 M
About XLIFE SCIENCES N
Sector
CEO
Oliver R. Baumann
Website
Headquarters
Zurich
ISIN
CH0461929603
FIGI
BBG0157TVP60
Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company was founded in 2019 and is headquartered in Zurich, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XLS is 34.3 CHF — it has increased by 0.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange XLIFE SCIENCES N stocks are traded under the ticker XLS.
XLS stock is 3.27% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is XLIFE SCIENCES N there?
Yes, you can track XLIFE SCIENCES N financials in yearly and quarterly reports right on TradingView.
XLS stock has risen by 0.29% compared to the previous week, the month change is a 23.78% fall, over the last year XLIFE SCIENCES N has showed a 7.19% increase.
XLS net income for the last quarter is 20.76 M CHF, while the quarter before that showed −5.88 M CHF of net income which accounts for 452.88% change. Track more XLIFE SCIENCES N financial stats to get the full picture.
No, XLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, XLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XLIFE SCIENCES N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XLIFE SCIENCES N technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XLIFE SCIENCES N stock shows the strong sell signal. See more of XLIFE SCIENCES N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. XLIFE SCIENCES N EBITDA is −4.38 M CHF, and current EBITDA margin is −443.56%. See more stats in XLIFE SCIENCES N financial statements.